Maravai LifeSciences Holdings, Inc.

NasdaqGS:MRVI Stock Report

Market Cap: US$1.4b

Maravai LifeSciences Holdings Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:MRVI Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Nov 24BuyUS$100,625John DeFordIndividual17,500US$5.75
11 Nov 24BuyUS$987,000Carl HullIndividual175,000US$5.64
28 May 24SellUS$97,570,660GTCR LLCCompany9,940,974US$9.82

Insider Trading Volume

Insider Buying: MRVI insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of MRVI?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders902,7200.599%
VC/PE Firms20,150,00513.4%
Hedge Funds22,364,46614.8%
Institutions107,248,72371.2%

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Top 25 shareholders own 86.77% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
14.2%
GTCR LLC
20,150,005US$192.6m0%4.68%
9.88%
12 West Capital Management LP
14,011,179US$134.0m6.06%6.95%
8.38%
The Vanguard Group, Inc.
11,881,740US$113.6m10.5%no data
7.39%
BlackRock, Inc.
10,476,083US$100.2m7.68%no data
5.89%
Braidwell LP
8,353,287US$79.9m-7.43%2.07%
4.49%
Mackenzie Financial Corporation
6,363,412US$60.8m8.58%0.04%
3.05%
Millennium Management LLC
4,325,312US$41.4m-27.5%0.02%
2.92%
Renaissance Technologies LLC
4,138,475US$39.6m6.62%0.03%
2.6%
Point72 Asset Management, L.P.
3,687,127US$35.3m-41.3%0.05%
2.54%
JP Morgan Asset Management
3,604,321US$34.5m3,160%no data
2.54%
Massachusetts Financial Services Company
3,601,725US$34.4m-20.9%no data
2.5%
Columbia Management Investment Advisers, LLC
3,549,502US$33.9m18.5%no data
2.1%
Jennison Associates LLC
2,980,645US$28.5m-34.6%0.01%
1.94%
Geode Capital Management, LLC
2,752,077US$26.3m6.28%no data
1.94%
State Street Global Advisors, Inc.
2,750,773US$26.3m-0.59%no data
1.75%
FMR LLC
2,478,294US$23.7m-5.99%no data
1.69%
First Trust Advisors LP
2,399,139US$22.9m0%0.01%
1.59%
Morgan Stanley, Investment Banking and Brokerage Investments
2,258,277US$21.6m93.7%no data
1.57%
The Glenmede Trust Company, National Association
2,226,034US$21.3m-1.41%0.06%
1.53%
Alyeska Investment Group, L.P.
2,168,348US$20.7m0.21%0.06%
1.5%
Baron Capital Group, Inc.
2,123,651US$20.3m0%0.03%
1.32%
Deutsche Asset & Wealth Management
1,866,135US$17.8m14.7%no data
1.26%
Portolan Capital Management, LLC
1,792,529US$17.1m-2.9%0.68%
1.14%
Systematic Financial Management LP
1,612,161US$15.4m14.7%0.21%
1.08%
Goldman Sachs Asset Management, L.P.
1,528,876US$14.6m353%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/22 05:06
End of Day Share Price 2024/12/20 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Maravai LifeSciences Holdings, Inc. is covered by 17 analysts. 16 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Catherine Ramsey SchulteBaird
Michael RyskinBofA Global Research
Matthew HewittCraig-Hallum Capital Group LLC